Five-year update on the mouse model of orthotopic lung transplantation: Scientific uses, tricks of the trade, and tips for success

Journal of Thoracic Disease

Volumn 4, Issue 3, 2012, Pages 247-258

  Lin, Xue ^a   Li, Wenjun ^a   Lai, Jiaming ^b   Okazaki, Mikio ^a,c   Sugimoto, Seiichiro ^a,d   Yamamoto, Sumiharu ^a   Wang, Xingan ^a   Gelman, Andrew E ^a,e   Kreisel, Daniel ^a,e   Krupnick, Alexander Sasha ^a  

^a WASHINGTON UNIVERSITY   (United States)

^b SUN YAT SEN UNIVERSITY   (China)

^c EHIME UNIVERSITY   (Japan)

^d OKAYAMA UNIVERSITY HOSPITAL   (Japan)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Evaluation; Mouse model; Orthotopic lung transplantation; Surgical complications

Indexed keywords

TISSUE ADHESIVE;

ACUTE GRAFT REJECTION; ARTERIAL GAS; ARTICLE; ATELECTASIS; BLOOD GAS ANALYSIS; BRONCHIOLITIS OBLITERANS; CHRONIC GRAFT REJECTION; CLINICAL EVALUATION; CUFF; FLUORESCENCE MICROSCOPY; GRAFT RECIPIENT; LUNG GRAFT REJECTION; LUNG LAVAGE; LUNG TRANSPLANTATION; NONHUMAN; NYLON SUTURE; PNEUMOTHORAX; POSTOPERATIVE COMPLICATION; POSTOPERATIVE THROMBOSIS; PRIMARY GRAFT DYSFUNCTION; PULMONARY VENOUS THROMBOSIS; REPERFUSION INJURY; STROMA CELL; SURGICAL TECHNIQUE; TISSUE REPAIR; VEIN THROMBOSIS;

EID: 84864494058     PISSN: 20721439     EISSN: 20776624     Source Type: Journal    
DOI: 10.3978/j.issn.2072-1439.2012.06.02     Document Type: Article

References (94)

1. Okazaki M, Krupnick AS, Kornfeld CG, et al. A mouse model of orthotopic vascularized aerated lung transplantation. Am J Transplant 2007;7:1672-9.
2. Gelman AE, Okazaki M, Sugimoto S, et al. CCR2 regulates monocyte recruitment as well as CD4 Tl allorecognition after lung transplantation. Am J Transplant 2010;10:1189-99.
3. Kreisel D, Lai J, Richardson SB, et al. Polarized alloantigen presentation by airway epithelial cells contributes to direct CD8+ T cell activation in the airway. Am J Respir Cell Mol Biol 2011;44:749-54.
4. Kreisel D, Richardson SB, Li W, et al. Cutting edge: MHC class II expression by pulmonary nonhematopoietic cells plays a critical role in controlling local inflammatory responses. J Immunol 2010;185:3809-13.
5. Krupnick AS, Lin X, Li W, et al. Orthotopic mouse lung transplantation as experimental methodology to study transplant and tumor biology. Nat Protoc 2009;4:86-93.
6. Li W, Sugimoto S, Lai J, et al. Orthotopic vascularized right lung transplantation in the mouse. J Thorac Cardiovasc Surg 2010;139:1637-43.
7. Okazaki M, Gelman AE, Tietjens JR, et al. Maintenance of airway epithelium in acutely rejected orthotopic vascularized mouse lung transplants. Am J Respir Cell Mol Biol 2007;37:625-30.
8. Burlingham WJ, Love RB, Jankowska-Gan E, et al. IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants. J Clin Invest 2007;117:3498-506.
9. Fan L, Benson HL, Vittal R, et al. Neutralizing IL-17 prevents obliterative bronchiolitis in murine orthotopic lung transplantation. Am J Transplant 2011;11:911-22.
10. Shilling RA, Wilkes DS. Role of Th17 cells and IL-17 in lung transplant rejection. Semin Immunopathol 2011;33:129-34.
11. Sumpter TL, Wilkes DS. Role of autoimmunity in organ allograft rejection: a focus on immunity to type V collagen in the pathogenesis of lung transplant rejection. Am J Physiol Lung Cell Mol Physiol 2004;286:L1129-39.
12. Wilkes DS. Chronic lung allograft rejection and airway microvasculature: is HIF-1 the missing link? J Clin Invest 2011;121:2155-7.
13. Yasufuku K, Heidler KM, Woods KA, et al. Prevention of bronchiolitis obliterans in rat lung allografts by type V collagen-induced oral tolerance. Transplantation 2002;73:500-5.
14. Gelman AE, Okazaki M, Lai J, et al. CD4+ T lymphocytes are not necessary for the acute rejection of vascularized mouse lung transplants. J Immunol 2008;180:4754-62.
15. Gelman AE, Li W, Richardson SB, et al. Cutting edge: Acute lung allograft rejection is independent of secondary lymphoid organs. J Immunol 2009;182:3969-73.
16. Huang HJ, Sugimoto S, Lai J, et al. Maintenance of IKKbeta activity is necessary to protect lung grafts from acute injury. Transplantation 2011;91:624-31.
17. Okazaki M, Sugimoto S, Lai J, et al. Costimulatory blockade-mediated lung allograft acceptance is abrogated by overexpression of Bcl-2 in the recipient. Transplant Proc 2009;41:385-7.
18. Sugimoto S, Lin X, Okazaki M, et al. Monocyte differentiation is controlled by MyD88 after mouse orthotopic lung transplantation. Transplant Proc 2009;41:388-90.
19. Kreisel D, Sugimoto S, Zhu J, et al. Emergency granulopoiesis promotes neutrophil-dendritic cell encounters that prevent mouse lung allograft acceptance. Blood 2011;118:6172-82.
20. Jungraithmayr W, Weder W. The Technique of Orthotopic Mouse Lung Transplantation as a Movie-Improved Learning by Visualization. Am J Transplant 2012;12:1624-6.
21. De Vleeschauwer S, Jungraithmayr W, Wauters S, et al. Chronic rejection pathology after orthotopic lung transplantation in mice: the development of a murine BOS model and its drawbacks. PLoS ONE 2012;7:e29802.
22. Jungraithmayr W, De Meester I, Matheeussen V, et al. CD26/DPP-4 inhibition recruits regenerative stem cells via stromal cell-derived factor-1 and beneficially influences ischaemia-reperfusion injury in mouse lung transplantation. Eur J Cardiothorac Surg 2012;41:1166-73.
23. Jungraithmayr W, Draenert A, Marquardt K, et al. Ultrastructural changes in acute lung allograft rejection: novel insights from an animal study. J Heart Lung Transplant 2012;31:94-100.
24. Iken K, Liu K, Liu H, et al. IDO and Metabolites Protect Mouse Lung Allografts and Impair Calcium Mobilization of T Cells. Am J Respir Cell Mol Biol 2012. [Epub ahead of print].
25. Waki N, Yamane M, Yamamoto S, et al. Egrl: a novel target for ameliorating acute allograft rejection in an experimental lung transplant model. Eur J Cardiothorac Surg 2012;41:669-75.
26. Jungraithmayr WM, Korom S, Hillinger S, et al. A mouse model of orthotopic, single-lung transplantation. J Thorac Cardiovasc Surg 2009;137:486-91.
27. Kreisel D, Gelman AE, Palmer SM. In pursuit of new experimental models of obliterative bronchiolitis. Am J Transplant 2011;11:882-3.
28. Kreisel D, Nava RG, Li W, et al. In vivo two-photon imaging reveals monocyte-dependent neutrophil extravasation during pulmonary inflammation. Proc Natl Acad Sci USA 2010;107:18073-8.
29. Krupnick AS, Tidwell VK, Engelbach JA, et al. Quantitative monitoring of mouse lung tumors by magnetic resonance imaging. Nat Protoc 2012;7:128-42.
30. Nava RG, Li W, Gelman AE, et al. Two-photon microscopy in pulmonary research. Semin Immunopathol 2010;32:297-304.
31. Kling MA. A review of respiratory system anatomy, physiology, and disease in the mouse, rat, hamster, and gerbil. Vet Clin North Am Exot Anim Pract 2011;14:287-337.
32. Morgan GE, Mikhail MS, Murray MJ. Clinical anesthesiology. 4th ed. New York: Lange Medical Books/McGraw Hill, Medical Pub. Division; 2006. xiv, 1105 p. p.
33. Irvin CG, Bates JH. Measuring the lung function in the mouse: the challenge of size. Respir Res 2003;4:4.
34. Knudsen L, Weibel ER, Gundersen HJ, et al. Assessment of air space size characteristics by intercept (chord) measurement: an accurate and efficient stereological approach. J Appl Physiol 2010;108:412-21.
35. Gomes RF, Bates JH. Geometric determinants of airway resistance in two isomorphic rodent species. Respir Physiol Neurobiol 2002;130:317-25.
36. Greschus S, Kuchenbuch T, Plotz C, et al. Monitoring of experimental rat lung transplants by high-resolution flat-panel volumetric computer tomography (fpVCT). J Invest Surg 2009;22:69-75.
37. Santacruz JF, Mehta AC. Airway complications and management after lung transplantation: ischemia, dehiscence, and stenosis. Proc Am Thorac Soc 2009;6:79-93.
38. Tendulkar RD, Fleming PA, Reddy CA, et al. High-dose-rate endobronchial brachytherapy for recurrent airway obstruction from hyperplastic granulation tissue. Int J Radiat Oncol Biol Phys 2008;70:701-6.
39. Kennedy AS, Sonett JR, Orens JB, et al. High dose rate brachytherapy to prevent recurrent benign hyperplasia in lung transplant bronchi: theoretical and clinical considerations. J Heart Lung Transplant 2000;19:155-9.
40. Shennib H, Massard G. Airway complications in lung transplantation. Ann Tnorac Surg 1994;57:506-11.
41. Van De Wauwer C, Van Raemdonck D, Verleden GM, et al. Risk factors for airway complications within the first year after lung transplantation. Eur J Cardiothorac Surg 2007;31:703-10.
42. Mulligan MS. Endoscopic management of airway complications after lung transplantation. Chest Surg Clin N Am 2001;11:907-15.
43. Choong CK, Sweet SC, Zoole JB, et al. Bronchial airway anastomotic complications after pediatric lung transplantation: incidence, cause, management, and outcome. J Thorac Cardiovasc Surg 2006;131:198-203.
44. Marck KW, Piers DA, Wildevuur CR. Lung transplantation in the rat: II. lung perfusion scintigraphy in normal and left lung-transplanted rats. Ann Tnorac Surg 1982;34:81-8.
45. Marck KW, Prop J, Wildevuur CR. Lung transplantation in the rat. III. Functional studies in iso-and allografts. J Surg Res 1983;35:149-58.
46. Zweers N, Petersen AH, van der Hoeven JA, et al. Donor brain death aggravates chronic rejection after lung transplantation in rats. Transplantation 2004;78:1251-8.
47. Reis A, Giaid A, Serrick C, et al. Improved outcome of rat lung transplantation with modification of the nonsuture external cuff technique. J Heart Lung Transplant 1995;14:274-9.
48. Yuh DD, Gandy KL, Morris RE, et al. Leflunomide prolongs pulmonary allograft and xenograft survival. J Heart Lung Transplant 1995;14:1136-44.
49. Stewart S, Fishbein MC, Snell GI, et al. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant 2007;26:1229-42.
50. Vanoirbeek JA, Rinaldi M, De Vooght V, et al. Noninvasive and invasive pulmonary function in mouse models of obstructive and restrictive respiratory diseases. Am J Respir Cell Mol Biol 2010;42:96-104.
51. Lee EJ, Woodske ME, Zou B, et al. Dynamic arterial blood gas analysis in conscious, unrestrained C57BL/6J mice during exposure to intermittent hypoxia. J Appl Physiol 2009;107:290-4.
52. Heron M, Grutters JC, Ten Dam-Molenkamp KM, et al. Bronchoalveolar lavage cell pattern from healthy human lung. Clin Exp Immunol 2012;167:523-31.
53. Vikis HG, Gelman AE, Franklin A, et al. Neutrophils are required for 3-methylcholanthrene-initiated, butylated hydroxytoluene-promoted lung carcinogenesis. Mol Carcinog 2011. [Epub ahead of print].
54. Miller MJ, Wei SH, Parker I, et al. Two-photon imaging of lymphocyte motility and antigen response in intact lymph node. Science 2002;296:1869-73.
55. Cahalan MD, Parker I, Wei SH, et al. Two-photon tissue imaging: seeing the immune system in a fresh light. Nat Rev Immunol 2002;2:872-80.
56. Cahalan MD, Parker I, Wei SH, et al. Real-time imaging of lymphocytes in vivo. Curr Opin Immunol 2003;15:372-7.
57. Miller MJ, Wei SH, Cahalan MD, et al. Autonomous T cell trafficking examined in vivo with intravital two-photon microscopy. Proc Natl Acad Sci USA 2003;100:2604-9.
58. Miller MJ, Hejazi AS, Wei SH, et al. T cell repertoire scanning is promoted by dynamic dendritic cell behavior and random T cell motility in the lymph node. Proc Natl Acad Sci USA 2004;101:998-1003.
59. Miller MJ, Safrina O, Parker I, et al. Imaging the single cell dynamics of CD4+ T cell activation by dendritic cells in lymph nodes. J Exp Med 2004;200:847-56.
60. Trulock EP, Edwards LB, Taylor DO, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-third official adult lung and heart-lung transplantation report-2006. J Heart Lung Transplant 2006;25:880-92.
61. Lee JC, Christie JD. Primary graft dysfunction. Clin Chest Med 2011;32:279-93.
62. Christie JD, Bavaria JE, Palevsky HI, et al. Primary graft failure following lung transplantation. Chest 1998;114:51-60.
63. Christie JD, Kotloff RM, Pochettino A, et al. Clinical risk factors for primary graft failure following lung transplantation. Chest 2003;124:1232-41.
64. Arcasoy SM, Kotloff RM. Lung transplantation. N Engl J Med 1999;340:1081-91.
65. Christie JD, Van Raemdonck D, de Perrot M, et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part I: introduction and methods. J Heart Lung Transplant 2005;24:1451-3.
66. Arcasoy SM, Fisher A, Hachem RR, et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part V: predictors and outcomes. J Heart Lung Transplant 2005;24:1483-8.
67. Christie JD, Carby M, Bag R, et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2005;24:1454-9.
68. King RC, Binns OA, Rodriguez F, et al. Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation. Ann Thorac Surg 2000;69:1681-5.
69. Daud SA, Yusen RD, Meyers BF, et al. Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 2007;175:507-13.
70. Kreisel D, Sugimoto S, Tietjens J, et al. Bcl3 prevents acute inflammatory lung injury in mice by restraining emergency granulopoiesis. J Clin Invest 2011;121:265-76.
71. Kotloff RM, Thabut G. Lung transplantation. Am J Respir Crit Care Med 2011;184:159-71.
72. Palmer SM, Burch LH, Davis RD, et al. The role of innate immunity in acute allograft rejection after lung transplantation. Am J Respir Crit Care Med 2003;168:628-32.
73. Larsen CP, Elwood ET, Alexander DZ, et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996;381:434-8.
74. Dodd-o JM, Lendermon EA, Miller HL, et al. CD 154 blockade abrogates allospecific responses and enhances CD4 (+) regulatory T-cells in mouse orthotopic lung transplant. Am J Transplant 2011;11:1815-24.
75. Sato M, Keshavjee S, Liu M. Translational research: animal models of obliterative bronchiolitis after lung transplantation. Am J Transplant 2009;9:1981-7.
76. De Vleeschauwer S, Vanaudenaerde B, Vos R, et al. The need for a new animal model for chronic rejection after lung transplantation. Transplant Proc 2011;43:3476-85.
77. Estenne M, Maurer JR, Boehler A, et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 2002;21:297-310.
78. Sato M, Keshavjee S. Bronchiolitis obliterans syndrome: alloimmunedependent and -independent injury with aberrant tissue remodeling. Semin Thorac Cardiovasc Surg 2008;20:173-82.
79. Todd JL, Palmer SM. Bronchiolitis obliterans syndrome: the final frontier for lung transplantation. Chest 2011;140:502-8.
80. Rocha PN, Plumb TJ, Crowley SD, et al. Effector mechanisms in transplant rejection. Immunol Rev 2003;196:51-64.
81. Dierselhuis M, Goulmy E. The relevance of minor histocompatibility antigens in solid organ transplantation. Curr Opin Organ Transplant 2009;14:419-25.
82. Fukami N, Ramachandran S, Saini D, et al. Antibodies to MHC class I induce autoimmunity: role in the pathogenesis of chronic rejection. J Immunol 2009;182:309-18.
83. Rolls HK, Kishimoto K, Dong VM, et al. T-cell response to cardiac myosin persists in the absence of an alloimmune response in recipients with chronic cardiac allograft rejection. Transplantation 2002;74:1053-7.
84. Barber LD, Whitelegg A, Madrigal JA, et al. Detection of vimentin-specific autoreactive CD8+ T cells in cardiac transplant patients. Transplantation 2004;77:1604-9.
85. Carter V, Shenton BK, Jaques B, et al. Vimentin antibodies: a non-HLA antibody as a potential risk factor in renal transplantation. Transplant Proc 2005;37:654-7.
86. Yousem SA. Lymphocytic bronchitis/bronchiohtis in lung allograft recipients. Am J Surg Pathol 1993;17:491-6.
87. Grayson MH, Holtzman MJ. Emerging role of dendritic cells in respiratory viral infection. J Mol Med (Berl) 2007;85:1057-68.
88. Hammad H, Lambrecht BN. Lung dendritic cell migration. Adv Immunol 2007;93:265-78.
89. Ray P, Krishnamoorthy N, Ray A. Emerging functions of c-kit and its ligand stem cell factor in dendritic cells: regulators of T cell differentiation. Cell Cycle 2008;7:2826-32.
90. Suzuki T, Chow CW, Downey GP. Role of innate immune cells and their products in lung immunopathology. Int J Biochem Cell Biol 2008;40:1348-61.
91. Lambrecht BN, Hammad H. The role of dendritic and epithelial cells as master regulators of allergic airway inflammation. Lancet 2010;376:835-43.
92. Chiappori AA, Soliman H, Janssen WE, et al. INGN-225: a dendritic cell-based p53 vaccine (Ad.p53-DC) in small cell lung cancer: observed association between immune response and enhanced chemotherapy effect. Expert Opin Biol Tner 2010;10:983-91.
93. Hollingsworth JW, Theriot BS, Li Z, et al. Both hematopoietic-derived and non-hematopoietic-derived {beta}-arrestin-2 regulates murine allergic airway disease. Am J Respir Cell Mol Biol 2010;43:269-75.
94. Kreisel D, Krupnick AS, Gelman AE, et al. Non-hematopoietic allograft cells directly activate CD8+ T cells and trigger acute rejection: an alternative mechanism of allorecognition. Nat Med 2002;8:233-9.